1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6E7F970F9FB6B3E87652583440030805C
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-best-practices-communicating-medical-information-types-information-shared-with-different-stakeholders?opendocument
18
19opendocument
2054.81.69.220
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Medical Affairs Medical Communication

Best Practices in Communicating Medical Information: Types of Information Shared with Different Stakeholders

ID: 5531


Features:

12 Info Graphics

23 Data Graphics

560+ Metrics

2 Narratives


Pages/Slides: 42


Published: 2018


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from “Best Practices in Communicating Medical Information: Types of Information Shared with Different Stakeholders”


STUDY OVERVIEW


Medical Information groups within pharmaceutical, biotechnology and medical device companies play a key role in the dissemination of vital information to different external stakeholders such as HCPs, payers, formulary decision makers, and clinical investigators.

To improve consistency and efficiency in meeting the informational needs of this diverse group of stakeholders, Medical Information groups need to prioritize the type of information to be shared with each stakeholder type and the method of communication.

Best Practices, LLC undertook this benchmarking research to probe how Medical Information groups within leading organizations share different types of on- and off-label information with an array of external stakeholders. This study also delves into the topic of proactive and reactive sharing of medical information.

Insights in this benchmarking study are presented into two segments: Large Companies Segment and Small-Mid Sized Companies Segment.

KEY TOPICS


  • Distribution of Medical Information with Different External Stakeholders
  • Proactive vs. Reactive Sharing of Medical Information

KEY METRICS


  • The information types used by Medical Information to communicate with HCPs
  • The information types used by Medical Information to communicate with payers (non-HCPs)
  • The information types used by Medical Information to communicate with formulary decision makers
  • The information types used by Medical Information to communicate with clinical investigators
  • The information types used by Medical Information to communicate with contracted HCP speakers
  • The information types used by Medical Information to communicate with government agencies
  • With the listed stakeholder groups, do you provide slide decks proactively, reactively or both?

SAMPLE KEY FINDINGS


  • Most Medical Information Provided to Stakeholders Reactively:
    • Medical Information groups send slide decks in a reactive manner following an unsolicited request specifically asking for slide decks on a specific topic.
    • Off-label information is communicated reactively, typically in PDF format.
    • Slide decks may be generated to handle frequently asked questions.

METHODOLOGY


Best Practices, LLC engaged 31 Medical Information professionals from 26 leading companies in this benchmarking research. Research analysis and recommendations are presented into two segments: Large Companies Segment (>$10B in revenue) and Small-Mid Sized Companies Segment (<$10B in revenue).


Industries Profiled:
Health Care; Pharmaceutical; Diagnostic; Biotech; Manufacturing; Consumer Products; Medical Device; Laboratories


Companies Profiled:
Abbott; AbbVie; Amicus Therapeutics; Bayer; Boehringer Ingelheim; BTG plc; CSL Behring; Depomed; Eisai; EMD Serono; Enlyton; Glenmark; GRAIL; Grifols; Jazz Pharmaceuticals; Juno Therapeutics; Medtronic; Merck; Merz Pharma; Novartis; Novo Nordisk; Pfizer; Pierre Fabre; Santen; Shire; Vifor Pharma

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.